Asian Pacific Journal of Cancer Prevention

  • 제16권14호
  • /
  • Pages.6061-6066
  • /
  • 2015
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Effects of Lycopene Alone or Combined with Melatonin on Methotrexate-Induced Nephrotoxicity in Rats

  • Oguz, Elif (Department of Medical Pharmacology, Harran University) ;
  • Kocarslan, Sezen (Department of Medical Pathology, Harran University) ;
  • Tabur, Suzan (Department of Endocrinology, Faculty of Medicine, Gaziantep University) ;
  • Sezen, Hatice (Department of Medical Biochemistry, Faculty of Medicine, Harran University) ;
  • Yilmaz, Zehra (Department of Medical Pharmacology, Harran University) ;
  • Aksoy, Nurten (Department of Medical Biochemistry, Faculty of Medicine, Harran University)
  • 발행 : 2015.09.02
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Methotrexate (Mtx), used for its anticancer and immunsuppresive properties, is known to be a nephrotoxic agent. We aimed to investigate the effects of lycopene (Lyc) alone or combined with melatonin (Mel) on Mtxinduced nephrotoxicity since both of these agents have antioxidant and anti-inflammatory effects. Nephrotoxicity was induced by intraperitoneal administration of methotrexate at a dose of 20 mg/kg. Treatment both with Lyc alone and Lyc combined with Mel provided significant reduction in tumor necrosis factor-alpha, interleukin 1-beta and ceruloplasmin levels in Mtx administered rats. Hovewer, Lyc combined with Mel provided a significant reduction also in NO levels. Hstopathological examination showed that there was an obvious improvement in the degenerative changes compared to Mtx administrated group with the Lyc combined Mel group giving best protection. In conclusion Lyc alone and combined with Mel provided significant improvement against renal damage caused by Mtx, preseumably via antioxidant and anti-inflammatory activities.

키워드

참고문헌

  1. Abdel-Raheem T, Khedr NF (2014). Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Naunyn Schmiedebergs Arch Pharmacol, 387, 341-53. https://doi.org/10.1007/s00210-013-0949-x
  2. Abelson HT, Fosburg MT, Beardsley GP, et al (1983). Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol, 1, 208-16.
  3. Abraham P, Kolli VK, Rabi S (2010). Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats. Cell Biochem Funct, 28, 426-33. https://doi.org/10.1002/cbf.1676
  4. Ahmadiasl N, Banaei S, Alihemati A, Baradaran B, Azimian E (2014). Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats. Clin Exp Nephrol, 18, 855-64. https://doi.org/10.1007/s10157-014-0937-6
  5. Al-Malki AL (2014). Synergestic effect of lycopene and melatonin against the genesis of oxidative stress induced by cyclophosphamide in rats. Toxicol Ind Health, 30, 570-5. https://doi.org/10.1177/0748233712459916
  6. Asvadi I, Hajipour B, Asvadi A, et al (2011). Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. Eur Rev Med Pharmacol Sci, 15, 1003-9.
  7. Atessahin A, Ceribasi AO, Yilmaz S (2007). Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol Toxicol, 100, 372-6. https://doi.org/10.1111/j.1742-7843.2007.00060.x
  8. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology, 212, 116-23. https://doi.org/10.1016/j.tox.2005.04.016
  9. Augusti PR, Conterato GM, Somacal S, et al (2007). Effect of lycopene on nephrotoxicity induced by mercuric chloride in rats. Basic Clin Pharmacol Toxicol, 100, 398-402. https://doi.org/10.1111/j.1742-7843.2007.00067.x
  10. Baydas G, Canatan H, Turkoglu A (2002). Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res, 32, 225-30. https://doi.org/10.1034/j.1600-079X.2002.01856.x
  11. Bozkurt M, Em S, Oktayoglu P, et al (2014). Carvacrol prevents methotrexate-induced renal oxidative injury and renal damage in rats. Clin Invest Med, 37, 19-25.
  12. Buyuklu M, Kandemir FM, Ozkaraca M, et al (2015). Benefical effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney. Hum Exp Toxicol, 34, 487-96. https://doi.org/10.1177/0960327114542964
  13. Cetinkaya A, Kurutas EB, Bulbuloglu E, Kantarceken B (2007). The effects of N-acetylcysteine on methotrexate-induced oxidative renal damage in rats. Nephrol Dial Transplant, 22, 284-5.
  14. Choudhury RC, Ghosh SK, Palo AK (2000). Cytogenetic toxicity of methotrexate in mouse bone marrow. Environ Toxicol Pharmacol, 3, 191-6.
  15. Christo JS, Rodrigues AM, Mouro MG, et al (2011). Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats. Nitric Oxide, 24, 77-83. https://doi.org/10.1016/j.niox.2010.12.001
  16. Clinton SK (1998). Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev, 56, 35-51.
  17. Cohen LA (2002). A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med, 227, 864-8.
  18. D'Adamo DR (2011). Appraising the current role of chemotherapy for the treatment of sarcoma. Seminars in Oncology, 38, 19-9. https://doi.org/10.1053/j.seminoncol.2011.09.004
  19. Devrim E, Cetin R, Kilicoglu B, et al (2005). Methotrexate causes oxidative stress in rat kidney tissues. Ren Fail, 27, 771-3. https://doi.org/10.1080/08860220500244823
  20. Di Mascio P, Kaiser S, Sies H (1989). Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys, 274, 532-8. https://doi.org/10.1016/0003-9861(89)90467-0
  21. Erel O (1998). Automated measurement of serum ferroxidase activity. Clin Chem, 44, 2313-9.
  22. Fiehn C (2011). The other opinion: nephrotoxicity of low-dose methotrexate-a problem which does not exist]. Z Rheumatol, 70, 825-6. https://doi.org/10.1007/s00393-011-0909-0
  23. Findlay M, von Minckwitz G, Wardley A (2008). Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol, 19, 212-22. https://doi.org/10.1093/annonc/mdm285
  24. Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007). Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol, 64, 517-526. https://doi.org/10.1111/j.1365-2125.2007.02911.x
  25. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK (2000). Ceruloplasmin and cardiovascular disease. Free Radic Biol Med, 28, 1735-44. https://doi.org/10.1016/S0891-5849(00)00231-8
  26. Fox PL, Mukhopadhyay C, Ehrenwald E (1995). Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci, 56, 1749-58. https://doi.org/10.1016/0024-3205(95)00146-W
  27. Gisondi P, Girolomoni G (2007). Biologic therapies in psoriasis: a new therapeutic approach. Autoimmun Rev, 6, 515-9. https://doi.org/10.1016/j.autrev.2006.12.002
  28. Gultekin F, Delibas N, Yasar S, Kilinc I (2001). In vivo changes in antioxidant systems and protective role of melatonin and a combination of vitamin C and vitamin E on oxidative damage in erythrocytes induced by chlorpyrifos-ethyl in rats. Arch Toxicol, 75, 88-96. https://doi.org/10.1007/s002040100219
  29. Hou YC, Janzuk A, Wang PG (1999). Current trends inmthe development of nitric oxide donors. Curr Pharm Des, 5, 417-41.
  30. Hrenak J, Paulis L, Repova K, et al (2015). Melatonin and renal protection: novel perspectives from animal experiments and human studies (review). Curr Pharm Des, 21, 936-49.
  31. Ibrahim MA, El-Sheikh AA, Khalaf HM, Abdelrahman AM (2014). Protective effect of peroxisome proliferator activator receptor (PPAR)-${\alpha}$ and -${\gamma}$ ligands againstmethotrexateinduced nephrotoxicity. Immunopharmacol Immunotoxicol, 36, 130-7. https://doi.org/10.3109/08923973.2014.884135
  32. Ito H, Fujita H, Takahashi T (2008). Diagnostic biomarkers of diabetic nephropathy. Expert Opin Med Diagn, 2, 61-9.
  33. Kedziora-Kornatowska K (2008). Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res, 45, 312-7. https://doi.org/10.1111/j.1600-079X.2008.00592.x
  34. Kirbas A, Cure MC, Kalkan Y, et al (2015). Effect of infliximab on renal injury due to methotrexate in rat. Iran J Kidney Dis, 9, 221-9.
  35. Koul A, Shubrant, Gupta P (2013). Phytomodulatory potential of lycopene from Lycopersicum esculentum against doxorubicin induced nephrotoxicity. Indian J Exp Biol, 51, 635-45.
  36. Kurcer Z, Parlakpinar H, Vardi N, et al (2007). Protective effects of chronic melatonin treatment against renal ischemia/ reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes, 115, 365-71. https://doi.org/10.1055/s-2007-971056
  37. Lameire N, Kruse V, Rottey S (2011). Nephrotoxicity of anticancer drugs-an underestimated problem. Acta Clin Belg, 66, 337-45.
  38. Li W, Wang G, Lu X, et al (2014). Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes. Int J Clin Exp Pathol, 7, 5008-15.
  39. Manikandan R, Beulaja M, Thiagarajan R, et al (2011). Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. Eur J Pharmacol, 30, 578-85.
  40. Miyazaki J, Kawai K, Hayashi H, et al (2003). The limited efficacy of methotrexate, actinomycin D and cisplatin (MAP) for patients with advanced testicular cancer. Jpn J Clin Oncol, 33, 391-5. https://doi.org/10.1093/jjco/hyg074
  41. Mohamed AM, Hosny AH, Mahmoud HM, et al (2005). The biochemical and morphological alterations following administration of melatonin, retinoic acid and nigella sativa in mammary carcinoma: an animal model. Int J Exp Pathol, 86, 383-96. https://doi.org/10.1111/j.0959-9673.2005.00448.x
  42. Mordente A, Guantario B, Meucci E, et al (2011). Lycopene and cardiovascular diseases: an update. Curr Med Chem, 18, 1146-63. https://doi.org/10.2174/092986711795029717
  43. Morsy MA, Ibrahim SA, Amin EF, et al (2013). Curcumin ameliorates methotrexate-induced nephrotoxicity in rats. Adv Pharmacol Sci, 387071.
  44. Moselhy SS, Al mslmani MA (2008).Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats. Mol Cell Biochem, 319, 175-80. https://doi.org/10.1007/s11010-008-9890-6
  45. Oguz E, Yilmaz Z, Ozbilge H (2015). Effects of melatonin on the serum levels of pro-inflammatory cytokines and tissue injury after renal ischemia reperfusion in rats. Ren Fail, 37, 318-22. https://doi.org/10.3109/0886022X.2014.991263
  46. Oktem F, Yilmaz HR, Ozguner F, et al (2006). Methotrexateinduced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health, 22, 241-7. https://doi.org/10.1191/0748233706th265oa
  47. Palabiyik SS, Erkekoglu P, Zeybek ND, et al (2013). Protective effect of lycopene against ochratoxin A induced renal oxidative stress and apoptosis in rats. Exp Toxicol Pathol, 65, 853-61. https://doi.org/10.1016/j.etp.2012.12.004
  48. Peters BP, Weissman FG, Gill MA. Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm, 57, 645-59.
  49. Pierine DT, Navarro ME, Minatel IO, et al (2014). Lycopene supplementation reduces TNF-${\alpha}$ via RAGE in the kidney of obese rats. Nutr Diabetes, 4, 142. https://doi.org/10.1038/nutd.2014.39
  50. Ramesh G, Reeves WB (2002). TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest, 110, 835-42. https://doi.org/10.1172/JCI200215606
  51. Renna S, Cottone M, Orlando A (2014). Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. World J Gastroenterol, 20, 9675-90. https://doi.org/10.3748/wjg.v20.i29.9675
  52. Rostoka E, Isajevs S, Baumane L, et al (2010). Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organ-specific in rats. Arh Hig Rada Toksikol, 61, 275-85.
  53. Seigers R, Schagen SB, Beerling W, et al (2008). Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance bymethotrexate in the rat. Behav Brain Res, 186, 168-75. https://doi.org/10.1016/j.bbr.2007.08.004
  54. Sinanoglu O, Sezgin G, Ozturk G, et al (2012). Melatonin with 1,25-dihydroxyvitamin D3 protects against apoptotic ischemia-reperfusion injury in the rat kidney. Ren Fail, 34, 1021-6. https://doi.org/10.3109/0886022X.2012.700887
  55. Tapiero H, Townsend DM, Tew KD (2004). The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother, 58, 100-10. https://doi.org/10.1016/j.biopha.2003.12.006
  56. Uz E, Oktem F, Yilmaz HR, Uzar E, Ozgüner F (2005). The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected tomethotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem, 277, 165-70. https://doi.org/10.1007/s11010-005-5875-x
  57. Velmurugan B, Santhiya ST, Nagini S (2004). Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N'-nitro-N-nitrosoguanidine-induced genotoxicity. Pol J Pharmacol, 56, 241-5. https://doi.org/10.1211/0022357022737
  58. Wang C, Li C, Gong W, Lou T (2013). New urinary biomarkers for diabetic kidney disease. Biomark Res, 1, 9. https://doi.org/10.1186/2050-7771-1-9

피인용 문헌

  1. The Encapsulation of Lycopene in Nanoliposomes Enhances Its Protective Potential in Methotrexate-Induced Kidney Injury Model vol.2018, pp.1942-0994, 2018, https://doi.org/10.1155/2018/2627917
  2. Protective effect of lycopene against chemical and natural toxins: A review pp.09516433, 2018, https://doi.org/10.1002/biof.1458
  3. The protective role of melatonin in chemotherapy‐induced nephrotoxicity: a systematic review of non-clinical studies vol.14, pp.9, 2018, https://doi.org/10.1080/17425255.2018.1513492